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PREFACE 
This thesis is a review of research literature on the subject of 
essential hypertension. Papers have been selected from the areas of 
clinical psychology, psychophysiology, neurophysiology, the physiology 
of the circulation, and biochemistry. The selection of papers has been 
made with the intent of presenting as broad a view as possible of the 
character and etiology of hypertension. Critical evaluation of pub-
lished research in terms of methodology and validity of findings has 
been sacrificed to this primary objective of breadth and cohesion. The 
omission is intentional not only because such an approach would be 
beyond the scope and intent of this paper, but also because such a 
critical effort made upon so large an area of experimental research 
would prove both innept and presumptuous. 
Choice of publications was made on the basis of information con-
tained in the listings of the Cumulative Index Medicus (CIM), published 
by the National Library of Medicine. The facilities of the following 
libraries were used in the course of research: Oklahoma State Univer-
sity Library, Stillwater; Library of the School of Medicine, University 
of Oklahoma, Oklahoma City; Library of the School of Medicine, Univer-
sity of Michigan, Ann Arbor; Shiffman Medical Library, Wayne State 
University School of Medicine, Detroit. 
I am indebted to Dr. Arthur E. Harriman, Department of Psychology, 
Oklahoma State University, for having originally interested me in the 
iii 
relationship between psychology and physiology. I am also indebted 
to him for his sustained and sustaining encouragement and criticism 
during the course of this work. I wish to thank Dr. Philip Murphy and 
Dr. Harry B. Brobst, Department of Psychology, Oklahoma State Univer-
sity; Dr. Claude Desjardins, Department of Zoology, University of Texas 
at Austin, formerly Department of Physiological Sciences, Oklahoma State 
University, and Dr. Robert J. Henrickson, Department of Animal Science, 
Oklahoma State University, for their valuable assistance. 
I also wish to thank Mrs. Kathleen Allen, Stillwater, Oklahoma, and 
Mrs. Helen Merkel and Mrs. Helen Lewandowski of Southfield, Michigan for 
their able assistance in the preparation of early drafts of the manu-
script. I wish to thank Miss Dorian Martyn of Detroit, Michigan for her 
skillful preparation of the final copy of this thesis. 
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DEFINITION OF THE PROBLEM 
Introduction 
Those aspects of essential hypertension chosen for discussion in 
this paper will be introduced as several kinds of interaction. It will 
be seen that there is interaction between those brain mechanisms that 
govern emotional, motivational, and attitudinal states and the neuro-
endocrine secretions that determine the integrity of the arterial net-
work. There is an interaction between central state and the delicate 
buffer mechanism for control of systemic blood pressure that operates at 
the vascular confluence of brain and peripheral circulation, the carotid 
sinus and the aortic arch. Although there is a relative paucity of 
information on motor behavior and circulation in skeletal muscle in the 
hypertensive human, there are enough data from animal research in this 
area of physiology to provide a basis for conjecture on the role of 
striated muscle activity in human cardiovascular regulation. Any one of 
these systems may develop sufficient deviation from normal functioning 
to initiate elevation of blood pressure, or they may do so by acting in 
concert. 
The psychology of functional disorders has been studied exhaust-
ively and yet continues to elude satisfactory definition. It is pos-
sible, however, to correlate several kinds of evidence to arrive at a 
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definition for hypertension that seems plausible. This evidence will 
come from studies of the hypertensive personality, from research on the 
physiological specificity of emotional response, and from evidence, 
derived principally from animal studies, that certain emotional behav-
iors inevitably accompany sympathetic arousal under acute experimental 
conditions. 
It is hoped that this view of essential hypertension from several 
aspects may serve to illustrate how emotional, autonomic, and motor 
behavior can combine to produce disease. 
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CHAPTER II 
THE ROLE OF NEUROHUMORS, HORMONES, PEPTIDES, AND 
ENZYMES IN THE PATHOLOGY OF 
ESSENTIAL HYPERTENSION 
The Pressor Response 
Essential hypertension has three developmental stages. The first 
of these stages is the "diastolic reaction", or pre-hypertensive state, 
in which diastolic blood pressure is abnormally labile (Rambling, 1952). 
Benign essential hypertension, the subject of concern to this thesis, is 
also considered labile. In this stage of the disease, diastolic blood 
pressure remains fixed at a level somewhat in excess of 95 nun. Hg and 
hypertrophic alterations conunence in the arterial system (Rambling, 
1952) and in the left ventricle of the heart (Frolich, 1973). Malignant 
hypertension is characterized by a fixed level of diastolic blood pres-
sure well above 95 nun. Hg and by severe pathology of the heart, the 
kidneys and the blood vessels (Rambling, 1952). 
Morphologic changes in the cardiovascular system are inextricably 
related to chronically elevated blood pressure. Yet, it must be empha-
sized that both conditions are end-results of an essentially adaptive 
physiological mechanism: the pressor response. In its normal function-
ing, in both normal and hypertensive persons dealing with the exigencies 
of daily life, the cardiovascular system responds to sympathetic vaso-
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motor activity with quite considerable fluctuations in blood pressure 
(Bevan, Honour, and Stott, 1969; Charvat, Dell, and Folkow, 1964; 
Hinman, Engel, and BiclHord, 1962). The point at issue is how this 
flexible and life-supporting response becomes chronic, maladaptive, and 
ultimately life-threatening. 
The Neural Anatomy of the Pressor Response 
The pressor response is a mass discharge of the sympathetic branch 
of the autonomic nervous system. Centrally mediated, this response is 
the vasomotor expression of psychological drives that originate, in 
large part, from subcortical regions of the brain (Roberts, 1970; Zan-
chetti, 1970). Neurons in the hypothalamic-preoptic area, the limbic 
system, and the trajectory of the medial forebrain bundle that are 
specific to visceromotor, somatomotor, and sensory processes are also 
specific to emotionally motivated behavior (Folkow and Rubinstein, 1965; 
Flynn et al., 1970; Roberts, 1970; Wasman and Flynn, 1962; Zanchetti, 
1970). 
The hypothalamus, among all lower brain structures (Netter, 1958), 
has the major influence upon cardiovascular reactions as these relate to 
behavior (Bard, 1960; Nauta, 1972; Zanchetti, 1970), although its func-
tion in this regard is modulated by the carotid sinus/aortic arch inhib-
itory reflex (Bartorelli et al., 1959; Bizzi et al., 1961) and by the 
activity of the reticular formation (Malliani et al., 1963). When the 
defense reaction in the cat is evoked by electrical stimulation of the 
perifornical and medial forebrain bundle region of the postero-lateral 
hypothalamus (Ak.ert, 1961; Wasman and Flynn, 1962; Zanchetti, 1970), the 
reaction combines the pressor response, an alerting response, affective 
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display of either alarm or rage, and final escalation into escape or 
attack behavior with full engagement of the skeletal musculature (Abra-
hams and Hilton, 1958; Abrahams, Hilton, and Zbrozyna, 1960; Abrahams, 
Hilton, and Zbrozyna, 1964; Baccelli et al., 1965; Baccelli et al., 
1968; Folkow and Rubinstein, 1965; Folkow et al., 1968; Gloor, 1954; 
Hess, 1928; Zanchetti, 1970; Zanchetti et al., 1972). 
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Defined ever more precisely by numbers of investigators over many 
years, the pressor response is now understood to involve vasoconstric-
tion in the intestines, the kidneys, and the skin, accompanied by eleva-
tion of blood pressure, increase in cardiac output, (heart rate and 
stroke volume), and inhibition of intestinal and gastric motility 
(Abrahams and Hilton, 1958; Anderson and Brown, 1967; Cannon, 1928; 
Eliassen et al., 1951; Folkow, 1962.Q_; Folkow and Rubinstein, 1965; 
Folkow et al., 1968; Hess, 1954; Hess and Brugger, 1943; Masserman, 
1943; Morpurgo, 1968; Ranson and Magoun, 1939; Rosen, 1961; Wasman and 
Flynn, 1962). Vasoconstriction of the blood vessels in skeletal muscle 
occurs as part of the presser response when the body musculature is 
restrained or inhibited rather than actively mobilized under circum-
stances that call for defensive overt behavior (Baccelli et al., 1968). 
Muscle vasodilatation is concomitant, however, with vasoconstriction in 
the intestines and skin (Abrahams and Hilton, 1958; Eliassen et al., 
1951; Golenhofen, 1968; Uvnas, 1960~; Uvnas, 1960.Q..; Zanchetti et al., 
1972). However, because fluctuations in blood flow in skeletal muscle 
are more the result of vasodilator than of vasoconstrictor nerve influ-
ence (Golenhofen, 1968), muscle does not, in contrast to viscera and 
skin, provide a reliable indicator of the pressor response (Bhagat, 
1971; Delius et al., 1972; Rothe, 1966~; Rothe, 1966.Q_). 
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Internal Secretions and the Pressor Response 
There are three different kinds of substances internally secreted 
during sympathetic arousal that directly affect the peripheral circu-
lation. These will be described as (a) the acetic acid ester of choline, 
acetylcholine; (b) the catecholamines, epinephrine and its precursor, 
norepinephrine; and (c) the polypeptide, angiotensin amide II. Of the 
four substances, norepinephrine and angiotensin II are of greater impor-
tance in essential hypertension; norepinephrine because it is both a 
potent and pervasive vasoconstrictor and a mediator of both central and 
peripheral neural processes; angiotensin II, because it is also a vaso-
constrictor, and because its activity contributes to the coordinated 
functions of the kidney and the adrenal cortex. The two substances are 
important because there is a synergetic relationship between the nervous 
and hormonal functions that are controlled by norepinephrine, and the 
renal pressure reflex in which angiotensin II plays a part. Finally, 
they are important because each of these potent blood-borne messengers 
may have some abnormality in its metabolism that could contribute to the 
disease pathology. It must, however, be stressed that although these 
two secretions are demonstrably vasoactive, neither one, nor any other 
known secretion, is a mediator of hypertension in the sense of being a 
pressor substance found exclusively in the circulating plasma of hyper-
tensive organisms. No such substance has been found (Grollman, 1972). 
Acetylcholine 
Acetylcholine is the cholinergic neurotransmitter of the pregang-
lionic fibers of the sympathetic and of the pre- and postganglionic 
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fibers of the parasympathetic nervous systems. Its action is important 
in sympathetic mobilization for two reasons: (a) it is the neurohumor 
which mediates the release of epinephrine from the adrenal medulla; (b) 
it is the neurohumor secreted from sympathetic cholinergic vasodilatory 
fibers contained within peripheral sympathetic nerves (Eliasson et al., 
1951; Grollman, 1969; Uvnas, 19602:_; Uvnas, 1960~_). These fibers origin-
ate in the motor cortex, the premotor cortex, the cingulate gyrus, and 
in the principal integrating center of the vasodilatory system, the 
anterior hypothalamus, through which all these fibers pass (Abrahams and 
Hilton, 1958; Abrahams et al., 1964; Eliasson et al., 1951; Folkow, 
1962~; Folkow, Johansson, and Oberg, 1959; Folkow, Heymans, and Neil, 
1965; Guyton, 1966; Rosen, 1961; Uvnas, 19602:,; Uvnas, 1960b). They 
project exclusively to the precapillary sphincters and to the arterioles 
in skeletal and cardiac muscle (Abrahams et al., 1960; Bolme, Ngai, and 
Rosell, 1967a; Cobbold et al., 1963; Folkow, Mellander, and Oberg, 1961; 
Folkow et al., 1965; Mellander, 1960; Rosell and Uvnas, 1962; Tower, 
1931; Uvnas, 1960a; Uvnas, 1960~). 
Epinephrine 
The catecholamine, epinephrine, is an adrenal medullary hormone. 
It is secreted from the chromaffin cells of the adrenal medulla in 
response to stimulation by sympathetic cholinergic preganglionic fibers 
(Rothe, 1966a). These cells are, therefore, modified sympathetic post-
ganglionic neurons that are stimulated to secrete epinephrine from their 
intracellular granules by acetylcholine (Milnor, 1974; Rothe, 1966a). 
Epinephrine produces profound metabolic and nervous effects by its 
acceleration of metabolic rate, heart rate, and liver glycogenolysis, 
its stimulation of cardiac output (Grollman, 1969; Guyton, 1966), and 
its facilitation of synaptic transmission (Rothe, 1966~). The hormone 
constricts the blood vessels of the mesentery, the kidney, and the 
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spleen, but it produces vasodilatation of the heart, liver, and skeletal 
muscle vasculature (Milnor, 1974). Skeletal muscle response to epin-
ephrine has, however, been shown to be dose-dependent. Celander (1954) 
produced near maximum vasodilatation at low concentrations of infused L-
epinephrine (0.05 ug./kg./min.) and vasoconstriction at higher dose 
levels in the decentralized blood vessels of the leg muscles in the cat. 
The cross-over point from vasodilatation to vasoconstriction was 2 ug./kg./ 
min. infusion rate. 
Norepinephrine 
Norepinephrine is both an adrenal medullary hormone and an adren-
ergic neurohumor of the central and sympathetic nervous systems. In the 
brain and spinal cord, norepinephrine acts as a trans-synaptic mediator 
(Glowinski and Baldessarini, 1966) and as both an excitatory and inhibi-
tory synaptic transmitter (Margules, 1968). Adrenergic nerve terminals, 
originating from cell bodies in the pons and medulla oblongata, extend 
in high concentration to the medial forebrain bundle (MFB), the hypo-
thalamus, the reticular formation, the preoptic area, and the limbic 
system, with other collaterals extending to the cerebellum, the spinal 
cord, and to the entire cerebral cortex (Dahlstrom and Fuxe, 1965; 
Folkow and Neil, 1971; Fuxe, 1965; Fuxe, Hokfelt, and Jonsson, 1970; 
Hillarp, Fuxe, and Dahlstrom, 1966; Lichtensteiger and Langemann, 1966; 
Schildkraut and Kety, 1967; Stein and Wise, 1969; Vogt, 1954). 
Noradrenergic neurons in the vasomotor center of the medulla 
oblongata within the brainstem reticular formation are active neural 
elements in an autoregulatory system for blood pressure control within 
the central nervous system (Folkow and Neil, 1971). In the body peri-
phery, as an agent of sympathetic nervous activity and as a hormone 
released into the general circulation from the adrenal gland, norepin-
ephrine has a pronounced influence upon total peripheral resistance and 
systemic blood pressure because it exerts a strong constrictive effect 
upon virtually the entire vasculature (Grollman, 1969). This effect is 
most marked on the vessels of the skin and kidneys and is less pro-
nounced and more irregular on skeletal muscle blood vessels (Brod et 
al., 1969). 
Norepinephrine and Emotion 
9 
The details of adrenergic morphology are signigicant not only when 
related to the chronic elevation of blood pressure, but also when related 
to the emotional behaviors that are more commonly associated with hyper-
tension. The MFB, holding the largest concentration of ascending nor-
adrenergic fibers in the diencephalon (Heller, Seiden, and Moore, 1966) 
is that part of the brain critical to so-called "hypothalmic-preoptic 
motivational mechanisms" (Roberts, 1970), mechanisms that largely con-
trol the behaviors of threat, attack, and mating. Other sites of adren-
ergic innervation, the preoptic area, the limbic system, and the hypo-
thalamus are also subcortical structures associated with emotion and 
emotionally motivated behavior (Anden, Carlsson, and Haggendal, 1969; 
Bliss and Zwanziger, 1966; Flynn et al., 1970; Fuxe et al., 1970; Hag-
gendal and Lindquist, 1964; Mowbray and Rodger, 1970; Olds, 1962; Olds 
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et al., 1964; Reis and Gunne, 1965; Stein and Wise, 1969; Wise and 
Stein, 1969). 
Synthesis and Storage of Norepinephrine 




Source: Costa, E. and N. H. Neff. 1966. Isotopic and non-
isotopic measurements of the rate of catecholamine 
biosynthesis, p. 152. In E. Costa, L. J. Cote, and M. 
D. Yahr. (eds.) Biochemistry and pharmacology of 
the basal ganglia. Raven Press, New York. 
Figure 1. Sketch Illustrating the Synthesis of the Cate-
cholamine, Norepinephrine, from the t?( -
Amino Acid, Tyrosine. 
In spite of its wide distribution in the brain, norepinephrine is. 
synthesized in relatively small quantities in brain tissue compared to 
the total metabolism of the amine in the body (Tepperman, 1968; Wurtman, 
19652_; Wurtman, 1965b). Furthermore, brain tissue does not absorb nor-
epinephrine from the general circulation since a blood-brain barrier to 
norepinephrine and to its metabolite, normetanephrine, is known to exist 
(Anden et al., 1969; Glowinski, Kopin, and Axelrod, 1965; Schildkraut, 
1967; Uddin and Green, 1967). Tyrosine [2-Amino-3 (p-hydroxyphenyl) 
proprionic acid], the phenolic amino acid precursor of norepinephrine 
(Uddin and Green, 1967) does pass across the blood-brain barrier and is 
thought to do so by means of a specific transport mechanism rather than 
by passive diffusion (Chirigos, Greengard, and Udenfriend, 1960). 
Intraperitoneal injection of L-tyrosine in rats has shown that the amino 
acid as readily penetrates brain tissue as it does plasma and skeletal 
muscle, although the site of transport into the brain has not been 
defined (Chirigos et al., 1960). 
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The neuronal storage granule within the postganglionic sympathetic 
neuron is the principal peripheral source of norepinephrine as a neuro-
humor in plasma, exceeding its output as a hormone from the adrenal 
gland (von Euler, 1956; Falck, 1962; Wurtman, 1965~; Wurtman, 1965.E_). 
Countless nerve fiber terminals containing clusters of such vesicles are 
present in nearly all body tissue (Wurtman, 1965~; Wurtman, 1965.E_) and 
are richly distributed in those organs of the body that are sympathet-
ically innervated (Falck, 1962). These terminals are more sparcely 
distributed in the vasculature (Bhagat, 1971) and in the brain (Anden et 
al., 1966; Glowinski, 1970). As a hormone, norepinephrine is secreted 
from the chromaffin tissue of the adrenal medulla (Bhagat, 1971; Bolme 
et al., 1967~; von Euler, 1956; Falck, 1962; Fuxe, 1965: Fuxe and Hokfelt, 
1970; Glowinski, 1970; Vogt, 1954). 
By a process known as fractional turnover (Louis et al., 1969), 
norepinephrine is continuously released from vesicles into the cytoplasm 
of the nerve cell before it is released as a physiologically active 
neurotransmitter into the sympathetic neuroeffector junction (Uddin and 
Green, 1967; Wurtman, 1965~; Wurtman, 1965.E_). Berman and Siggins (1968) 
have postulated that Schwann cell-free terminal areas of postganglionic 
sympathetic vasoconstrictor fibrils are the sites of humeral release, 
and that these areas are located at discrete neuromuscular junctions in 
the walls of blood vessels. These sites have been further described as 
lying in the adventitial, or external layer and in the tunica media, or 
middle coat, the layer of the vessel wall that encloses the smooth 
muscle fibers (Anderson and Brown, 1967; Brick, Hutchison, and Roddie, 
1968; Brown, 1969; Burn, 1967; Burn, 1969; Falck, 1962). 
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Measurement of the specific activity of organ tissue catecholamines 
in mice has been performed by intravenous injection of radioactive 
tyrosine (L-tyrosine-H3, DL-tyrosine-3-c14), and radioactive DOPA (DL-
dihydroxyphenylalanine-H3), this last substance being a radioisotope of 
3,4-dihydroxyphenylalanine, an intermediate in the catabolism of tyrosine 
and precursor of norepinephrine (Burack and Draskoczy, 1964). The 
procedure has identified the spleen, adrenal medulla, and particularly 
the liver and heart as significant sites of storage and synthesis (total 
turnover). 
The rate of synthesis of norepinephrine from tyrosine is a negative 
function of the level of free, unbound, norepinephrine in the cytoplasm 
of the adrenergic and the chromaffin cell (Axelrod and Kopin, 1969; 
Costa and Neff, 1966). Norepinephrine is unbound when it has not yet 
been rendered physiologically inert following sympathetic nerve dis-
charge and hormonal release. To be bound, norepinephrine must be taken 
up into the granulated vesicles within aminergic central and pre-synaptic 
sympathetic fiber terminals and into the adrenal medullary chromaffin 
cell (Goodall and Kirshner, 1958; Uddin and Green, 1967). Surface 
binding of the amine also occurs in collagenic tissue and in the base-
ment membrane of all smooth muscle cells (Gillespie, 1968). 
Two experiments (Burack and Draskoczy, 1964; Trendelenburg, 1961) 
have provided pharmacological evidence that norepinephrine may be retained 
in two pools within the individual granule in the postganglionic nerve 
ending. The first such pool is presumed to be small, functional, and a 
source of readily available norepinephrine during sympathetic innervation. 
This storage site also seems susceptible to rapid depletion when the 
adrenergic nerve fiber is stimulated at frequencies that are supra-
physiological (Folkow, Haggendal, and Lisander, 1967). The second pool 
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is larger, non-functional, and only slowly transfers its contents to the 
functional pool. This model for the compartmentalized storage of norepin-
ephrine in the nerve fiber was first conceptualized by Trendelenburg 
(1961) in a report on the dose-response curve to intravenous injection 
of the sympathomimetic drug, tyramine hydrochloride, in the spinal cat. 
In measuring blood pressure, heart rate, and the response of the nicitat-
ing membrane, he observed a "transmission fatigue" which he interpreted 
as resulting from reduction of "available", rather than "bound", norepin-
ephrine. Burack and Draskoczy (1964) not only proposed two storage 
pools for norepinephrine, but also suggested that radioactive labeling 
of norepinephrine in nervous tissue may be nonhomogenous. They noted a 
differentiated rate of decline in specific activity of norepinephrine in 
the brain, heart, spleen, adrenal gland, and liver of mice after intra-
venous injection of radioactive tyrosine and radioactive DOPA. Trendelen-
burg (1964) argued that both conditions are indeed possible and his view 
has gained acceptance by other investigators (Folkow, Haggendal, and 
Lisander, 1967; Kopin, 1964; Sedvall, Weise, and Kopin, 1968; Weissman, 
Koe, and Tenen, 1966). 
Monamine oxidase (MAO) is the enzyme that subjects norepinephrine 
to deamination when it is in the free state in the cytoplasm of the 
neuron (Uddin and Green, 1967). MAO is a mitochondrial isozyme (Fuller, 
1972; Markert and Moller, 1959), meaning that it is either a protein of 
differing molecular forms, or that it is more than a single protein 
(Diaz Borges and D1 Iorio, 1972; Youdim, 1972). The level of unbound 
norepinephrine is determined both by the relative activity of MAO 
(Montcastle and Baldessarini, 1974), and by the availability of binding 
sites within the vesicles (Weise, Sedvall, and Kopin, 1967). 
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Binding of norepinephrine is generally considered to be the princi-
pal inactivating mechanism because the bound amine is neither susceptible 
to cytoplasmic deamination by MAO nor to 0-methylation at the synapse by 
the enzyme, catechol-0-methyl-transferase (COMT) (Bhagat, 1971; Hertting 
and Axelrod, 1961; Louis et al., 1969; Panisset and Bourdois, 1968; 
Wurtman, 1965i!3 Wurtman, 1965E_), This view of the binding mechanism 
does not, however, rest unchallenged. Studies of norepinephrine dis-
position in strips of rabbit thoracic aorta (Kalsner and Nickerson, 
1969) have shown deamination and 0-methylation to be more effective 
mechanisms of inactivation than vesicular binding. The finding may be 
explained by the discovery that binding in rabbit aortic strips takes 
place in the adventitia and underlying portion of the media of vascular 
smooth muscle, but that enzymatic breakdown of norepinephrine is the 
principal deactivating process in the greater part of the media (Levin 
and Furchgott, 1970). 
Biosynthesis of norepinephrine can be increased when tissue is 
sympathetically stimulated (Anden, Fuxe, and Hokfelt, 1966; Weiner and 
Rabadjija, 1968). A relatively high rate of synthesis can also be a 
function of dense concentration in tissue of adrenergic nerve processes 
(Turner, 1966; Uddin and Green, 1967). When, for example, the stellate 
ganglia of the rat are electrically stimulated, the resultant increase 
in heart rate (90% above control levels) is accompanied by a pronounced 
(2-fold) increase in norepinephrine synthesis (Gordon et al., 1966). 
The systemic adrenergic influence of the heart is in fact so considerable 
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that it has been described as a neuroendocrirue organ by Braunwald, 
Harrison, and Chidsey (1964). They found that mean arterial pressure 
and the contractile force of the right ventricle in the dog were signifi-
cantly increased by the reinfusion of blood initially withdrawn from the 
coronary sinus following electrical stimulation of the cardiac sympa-
thetic nerves. They found also that stimulation of the cardiac nerves 
in the dog produced a definite pressor effect following severance of the 
cardiac nerves from the rami and all central afferentations and adminis-
tration of the beta (adrenergic) receptor blocking agent, Nethalide. 
The Renin-Angiotensin System 
Angiotensin II, an octapeptide, is an indirect product of the 
interaction between the proteolytic enzyme, renin, and angiotensinogen 
(alpha2-globulin) which is a renin-substrate in plasma (Lubash, 1968; 
Pitts, 1968). Renin is released from the juxtaglomerular cells, the 
"intrarenal baroreceptors" in the afferent arterioles leading to the 
nephron of the kidney (Pitts, 1968). These granular cells respond to 
reduction in urinary sodium, to sympathetically induced partial renal 
anoxia, and to reduced renal perfusion pressure (Lubash, 1968). By 
reacting with angiotensinogen, renin liberates angiotensin I, the virtu-
ally inactive decapeptide precursor of angiotensin II (Pitts, 1968). 
Angiotensin II is an unstable and probably minute blood constituent 
under normal conditions (Zweifach, 1968), but it is, nonetheless, con-
sidered "by weight, the most powerful pressor substance known" (Lubash, 
1968). 
The renin-angiotensin system and the adrenal cortex form a negative 
feedback loop that modulates renal perfusion pressure, blood volume, and 
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the internal balance of sodium (Na), potassium (K), and water (Abboud, 
1968; Gantt, 1967; Haber, 1969). Angiotensin II evidently inhibits the 
active transport, or resorption, of sodium into the renal tubules and of 
potassium into the adrenal cortex. These inhibitions disturb the extra-
cellular Na/K ratio, causing sufficient imbalance to stimulate the 
secretion of the mineralocorticoid, aldosterone, from the zona glomerulosa 
cells of the adrenal cortex (Szalay, 1969). Aldosterone promotes the 
resorption of sodium into the renal tubules and the conservation of body 
water, adjustments that serve as inhibitory stimuli to the secretion of 
renin from the juxtaglomerular cells of the kidney (Lubash, 1968; Tanaka 
et al., 1969), A study of aldosterone pre-treated guinea-pigs has shown 
that aldosterone in fact fulfills antagonistic functions, at once pro-
moting the pressor effects of angiotensin II and inhibiting the secre-
tion of renin from the kidney (Beretta, Aguggini, and Rubbiani, 1967). 
As a vasoconstrictor, angiotensin II has strong effect upon the 
vasculature of the kidney, moderate effect upon the blood vessels of the 
skin, and a sustained constrictor effect upon the vessels of striated 
muscle (Brod et al., 1969). The magnitude of these effects depends, in 
part, on the concentration of sodium at the receptor site (Blair-West, 
Harding, and McKenzie, 1968). The pressor function of angiotensin II 
does not seem to be centrally mediated. It has been injected into the 
vertebral and carotid arteries of the anesthetized dog in order to 
determine whether the maneuver might stimulate the vasomotor center 
(Zimmerman, 1967). Blood pressure elevation occurred only after the 
injection had caused constriction in the peripheral circulation and 
could not, therefore, be attributed to central stimulation. 
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The kidney has been found to exert an anti-hypertensive influence 
upon circulatory dynamics that plasma renin activity levels do not in 
themselves clearly reveal. Curiously, it moderates the cardiovascular 
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response to the end-products of its own secretions, for the kidney is a 
storage site of angiotensinase, the enzyme that destroys angiotensin II 
(Pitts, 1968). It has been found, furthermore, that bilateral nephrec-
tomy in the dog will produce an increase in mean arterial pressure 
(Bunag, Mccubbin, and Page, 1968; Tigerstedt and Bergman, 1898). This 
animal preparation has also demonstrated pronounced elevations in blood 
pressure following infusions of both angiotensin II and renin (McCubbin 
and Page, 1954). The protective, compensatory role of the kidney has 
been demonstrated by the renal hypertrophy detected in rats following 
injection of either D-aldosterone of deoxycorticosterone trimethylacetate 
(DOCA) (Ostrovsky, Papsin, and Gornall, 1968). Hypertrophy developed 
before blood pressure became elevated. Furthermore, a phospholipid has 
been isolated from the kidney of the dog and the hog (Sen, Smeby, and 
Bumpus, 1967) and from the blood plasma and erythrocytes of the dog and 
the human (Ostrovsky et al., 1967) that will reduce blood pressure and 
indirectly inhibit renin activity in renal hypertensive rats (Smeby, Sen 
and Bumpus, 1967). 
The Synergism between the Sympathetic Nervous 
System and the Renin-Angiotensin System 
There are two kinds of evidence to demonstrate the synergism be-
tween norepinephrine and the renin-angiotensin system. Electrical 
stimulation of the mesencephalic presser area (vasomotor center, bilateral 
portion) in the anesthetized dog elicits the release of renin from the 
kidney (Ueda et al., 1967). Sympathetic fibers either innervate the 
juxtaglomerular cells directly or indirectly stimulate the release of 
renin and the consequent formation of angiotensin II by influencing 
hemodynamic shifts and the balance of electrolytes (Ueda et al., 1967). 
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Because angiontensin II is a weak depolarizing agent (Kiran and 
Khairallah, 1969), the converse may be true: by increasing the perme-
ability of the cell membrane, angiotensin II probably augments the 
release of norepinephrine from the adrenergic neuron (Boadle, Hughes, 
and Roth, 1969; Day and Owen, 1968!!_; Day and Owen 1968b; Day and Owen, 
1969; Dickinson, de Swiet, and De Schaepdryver, 1968; Kiran and Khairal-
lah, 1969; Panisset and Bourdois, 1968; Peach and Ford, 1968; Turker and 
Kayaalp, 1967; Zimmerman, 1967). It is this biochemical property that 
may explain why angiotensin II infusion has been found to raise blood 
pressure and to produce a non-rhythmical efferent activity in the renal 
sympathetic nerve of the rabbit (Aars and Akre, 1968). This property 
may also explain the indirect stimulation of sympathetic ganglia (Lewis 
and Reit, 1965; Trendelenburg, 1966), the facilitation of ganglionic 
transmission (Haefely, Hurlimann, and Thoenen, 1966), and the direct 
stimulation of catecholamine secretion from the adrenal medulla (Lubash, 
1968; Tanaka et al., 1969) by angiotensin II. 
Renal-Adrenocortical Function in 
Essential Hypertension 
The anomaly in renal-adrenocortical function in hypertension may 
have to do with the relative activity levels of the enzyme, renin, and 
the salt-retaining hormone, aldosterone. Renin values have been found 
to be either normal or below normal in essential hypertension (Del 
Greco et al., 1967; Haber, 1969; Januszewicz, Baczko, and Wocial, 1969; 
Lubash, 1968; Matsuyama et al., 1967; Schonbeck et al., 1969). When 
neurogenic hypertension has been produced in rats by sinoaortic baro-
ceptor denervation, renin values have remained unchanged (Matsuyama et 
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al., 1967). When human subjects with essential hypertension have under-
gone the salivary Na/K ratio test (an index of mineralocorticoid excess), 
plasma renin activity has been found to be suppressed and to be accompanied 
by an increase in the concentration and activity level of aldosterone 
(Adlin, Channick, and Marks, 1969). Therefore, although the pressor 
effect of angiotensin can be somewhat offset by the hypotensive properties 
of the kidney, low plasma renin activity in essential hypertension will 
augment the salt-retaining capacity of aldosterone. This possibility is 
reasonable when it is recalled that the actions of angiotensin II and 
aldosterone are antagonistic and that angiotensin II is an indirect by-
product of renin activity. 
Noradrenergic Processes in Essential Hypertension 
The abnormality in the adrenergic process in essential hypertension 
has been presumed to be in the binding of norepinephrine. If granular 
storage capacity and sympathetic nervous activity can be assumed to be 
inversely related, decreased granular retention of norepinephrine must 
result in elevations of free norepinephrine in the cytoplasm of the 
chromaffin cell and aminergic neuron, in the bloodstream, and at the 
neuroeffector junction in smooth muscle. High blood pressure might then 
be expected to ensue from the generalized vasoconstriction which these 
elevations bring about (de Champlain, Krakoff, and Axelrod, 1967; de 
Champlain, Krakoff, and Axelrod, 1968; DeQuattro and Sjoerdsma, 1968; 
Gitlow et al., 1969; Kopin, 1964; Krakoff, de Champlain, and Axelrod, 
1967; Mendlowitz et al., 1961; Nestle and Doyle, 1968). One group of 
investigators (Louis et al., 1969) has, however, pointed out that these 
deductions are not entirely logical since defective binding necessarily 
exposes more norepinephrine to deamination by MAO. 
It is instead conceivable that some sort of intraneuronal auto-
regulation may occur during states of adrenergic activation, - that 
there exists a compensatory mechanism by which norepinephrine is meta-
bolically conserved, its concentration adjusted to the needs of the cell 
(Costa and Neff, 1966; Weise et al., 1967). Four separate studies not 
only suggest the possiblity of such a mechanism, but also illustrate 
some of the psychological and cardiovascular correlates of adrenergic 
activation. 
Goldberg and Salama (1969) found high norepinephrine content in the 
forebrain of rats following the muricidal (mouse-killing) response 
(25.5% increase) notwithstanding their pre-treatment with an inhibitor 
of norepinephrine synthesis, the tyrosine hydroxylase inhibitor, L-
alpha-methyl-para-L-tyronsine (d-MPT). Brain norepinephrine levels 
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have been seen to increase in male mice made aggressive by isolation and 
subjected to short, daily episodes of fighting and to being witness to 
fighting (Welch and Welch, 1971). These animals also developed high 
blood pressure and distinct cardiac hypertrophy within as short a time 
period as 10 days. High levels of norepinephrine have been found in the 
forebrain and cerebellum of spontaneously hypertensive rats (SHR) (Robert-
son et al., 1968). Lastly, muricidal and rod-gnawing responses in pre-
isolated SHR at varying ages (4.5, 19, and 42 weeks) have been found to 
be considerably more aggressive than these same behaviors in control 
rats (Shimamoto and Nagaoka, 1972). 
SHR, it should be explained, is considered one of the more appro-
priate experimental models of human essential hypertension (Knudsen, 
Iwai, and Dahl, 1973). In both this animal and in man, hypertension 
develops with age, and can be spontaneously elicited by environmental 
stimuli (Grollman, 1972). In SHR, it has been produced by forced immo-
bilization (stress loading) and by mild, continuous forms of visual, 
auditory, or electrical stimulation (Grollman, 1972; Okamoto and Oaki, 
1963; Okamoto, 1969; Phelan, Eryetishir, and Smirk, 1962; Smirk and 
Hall, 1968). As in man (McKusick, 1960), hypertension in SHR is poly-
genetically determined and regulated by a relatively small number of 
major genes (Hansen, 1972; Okamoto, 1969; Phelan et al., 1972; Tanase et 
al., 1972). Whereas organic malfunction or abnormality does not ini-
tiate hypertension in either man or SHR, both organisms are prone to 
cardiac hypertrophy and to hypertrophic and lesional pathology of the 
arteriolar network as the disease progresses (Folkow et al., 1972; 
Grollman, 1972; Phelan et al., 1972). 
In the Welch and Welch study (1971), post-mortem analysis of brain 
tissue disclosed increased amine levels in the telencephalon and dien-
cephalon-mesancephalon, the areas of the brain that contain noraminergic 
nerve terminals. Decreased levels were noted in the pons and medulla 
oblongata, the sites of the cell bodies. The discrepancy seemed to 
indicate that axoplasmic flow carrying neurotransmitter from cell body 
to nerve terminus (Dahlstrom and Haggendal, 1966; Kapeller and Mayor, 
1967; Laduron and Belpaire, 1968) can be accelerated by stimulation and 
that reduction of brain tissue oxygen tension (po2) may inhibit the 
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activity of MAO. The latter assumption evolved from a series of deduc-
tions made by Welch and Welch (1971) to defend the hypothesis of an 
intraneuronal autoregulatory process governing the metabolism of norepin-
ephrine. According to this view, norepinephrine is conserved under 
precisely those conditions of arousal in which it is most needed. 
These authors began with the implicit premise that oxygen utiliza-
tion in all body tissue is made possible by a respiratory chain of 
enzymes. This is a group of proteins, cytochromes, and nucleotides that 
are constituents of mitochondria (Chance, 1957). The isozyme, MAO, is 
part of the chain. It is an oxygenase, an enzyme that catalyzes the 
direct incorporation of the entire oxygen molecule into substrate 
(Mahler and Cordes, 1966). Regardless, therefore, of either substrate, 
tissue, or species, MAO is extremely sensitive to tissue reserves of 
dissolved oxygen, namely p02 (Davies and Bronk, 1957; Novick, 1966). 
Taking this property of MAO into account, Welch and Welch derived 
their second premise from oxygen cathode implantation studies of the 
cortical surfaces of the lightly anesthetized cat (Davies and Bronk, 
1957) and the normal conscious cat (Clark and Misrahy, 1957). Both 
studies reported spontaneous, rhythmic fluctuations in cortical po2 
resulting from alternating vasodilatation and vasoconstriction. These 
fluctuations indicated that normal cortical p02 levels were so low as to 
be marginal, never far from anoxia. This "disconcerting" discovery 
emerged, of course, from only localized investigation of the cortex 
· (Davies and Bronk, 1957). Welch and Welch nevertheless generalized from 
this finding to contend that stress that is specific to defensive, 
aggressive behavior may bring about widespread reduction of p02 within 
the central nervous system. They noted, further, that osmotic change 
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within the neuron during nerv~us excitement has been thought to cause 
either mitochondrial shrinkage or swelling (Lehninger, 1967), and that 
these structural modifications have been shown to lessen o2 consumption 
by mitochondria (Aebi, 1962). 
Within its limits, this argument may be plausible, but it does not 
take into account the effect of low po2 upon the rate-limiting step in 
the synthesis of norepinephrine. This step is the conversion of tyrosine 
to DOPA by the primary catalyst in the conversion process, tyrosine 
hydroxylase (Levitt et al., 1965; Nagatsu, Levitt, and Udenfriend, 
1964). The sensitivity of tyrosine hydroxylase to pOz has been ascer-
tained by studying its activity in high Oz atmosphere, both in vitro and 
in vivo. At a normal Oz atmosphere of 20 per cent, which creates an 
atmospheric pressure of approximately 159 mm. Hg, - normal tissue pOz 
being somewhat less than 70 mm. Hg (Neff and Costa, 1967) - oxygen has 
been found to virtually saturate the enzyme in vitro (Ikeda et al., 
1966). Reflecting this phenomena, catecholamine synthesis rate in heart 
and brain has been found to nearly double in rats subjected to an o2 
atmosphere of 100 per cent for a 1 hour period (Neff and Costa, 1967). 
MAO activity also presumably increased during this same time period. 
So it would seem that there are at least two explanations for the 
findings of the Welch and Welch experiment. First, aggressive behavior 
might indeed reduce po2 and by so doing, lessen the efficacy of mito-
chondria, of MAO, and of tyrosine hydroxylase. In this event, nor-
epinephrine would be protected from deamination even as its synthesis 
may be reduced. Conversely, aggressive behavior may increase po2• 
Such an increase should accelerate and counterbalance the activity of 
both enzymes, but it should finally favor the initial catalyst in nore-
pinephrine biosynthesis. In view of the nervous, hormonal, and myogenic 
processes that are known to come into play in the defense response, this 
second explanation seems closer to the facts. It also seems to be more 
biologically sound. 
Summary and Conclusions 
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The hypertensive response has been described in terms of adrenergic 
processes within the brain and autonomic nervous system in terms of 
vasoconstriction of the intestines, kidneys, and skin, in terms of 
circulation in skeletal muscle and, finally, in terms of cardiac acti-
vity. Of the internal secretions that directly influence the peripheral 
circulation, (acetylcholine, epinephrine, norepinephrine, and angiotensin 
II), the latter two not only appear to have the more acute and pervasive 
effect upon total peripheral resistance, but seem also to be synergistic 
in their effects on the renal pressor and sympathetic nervous systems. 
It is likely that the pressor effect of angiotensin II is somewhat off-
set by the normal hypotensive properties of the kidney. It may also be 
offset by low plasma renin activity, occasionally symptomatic of essential 
hypertension, that can augument the salt-retaining capacity of aldosterone. 
Although it is possible in hypertension that norepinephrine is not 
properly bound within the neuronal storage vesicle, there are two other 
plausible explanations for the heightened sympathetic nervous activity 
that is symptomatic of the disease. Stimulus-dependent suppression of 
the deaminating isozyme, MAO, may take place and increase the concentra-
tion of norepinephrine within the axon of the neuron; or, it is possible 
that stimulus-dependent acceleration of noradrenergic metabolism pro-
duces a substantial functional reserve of neurotransmitter. 
CHAPTER III 
THE BAROCEPTORS AND THE CONTROL OF 
SYSTEMIC BLOOD PRESSURE 
Sensitivity of the carotid sinus/aortic arch inhibitory reflex to 
blood pressure elevation has made it an important area of research on 
essential hypertension. The baroceptors of the carotid sinus and aortic 
arch, the vasomotor center in the reticular formation of the lower 
brainstem, the heart, and the peripheral arterial vessels are together 
considered an afferent-efferent reflex arc and a servocontrol system for 
systemic arterial pressure (Rosenbaum and Race, 1968). 
The Structure and Function of the Carotid 
Sinus/Aortic Arch Reflex 
Baroceptors have terminal end-plates that are attached to the 
adventitia and tunica media of the arch of the aorta and the internal 
carotid arteries (Abraham, 1969). These receptors are sensitive to mean 
intrasinusal pressure, to rate of change in arterial pressure, and to 
stretch or distortion of the arterial wall (Dell, 1972; Greenfield and 
Tindall, 1968; Heymans, 1968). The vagus and the glossopharyngeal 
nerves are the two afferent pathways from the sensor sites to the medial 
inhibitory portion of the bulbar vasomotor center, the center of the 
brain that continuously regulates vascular tone (Biscoe and Purves, 
1967; Bronk et al., 1936; Gernandt, Liljestrand, and Zotterman, 1946; 
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Raddy, Overbeck, and Daugherty, 1968; Miura and Reis, 1968; Sampson and 
Biscoe, 1968). Potentials evoked by direct electrical stimulation of 
the carotid sinus nerve and recorded in the commissural nucleus of 
Cajal, the nucleus of the solitary tract, and in various areas of the 
reticular formation in the anesthetized cat, have indicated that affer-
ent fibers of the sinus nerve make monosynaptic connections with the 
vasomotor center (Humphrey, 1966; Miura and Reis, 1968; Sampson and 
Biscoe, 1968). 
These various structures perform the critical function of main-
taining a predominantly steady non-pulsatile blood flow to the brain 
through the internal carotid arteries at normal ranges of blood pressure 
(Dell, 1972; Greenfield and Tindall, 1968; Heymans, 1968). Because the 
inhibitory reflex is frequency-dependent, it is set in motion by pulsa-
tile intrasinusal pressure brought about by rise in blood pressure and 
increase in heart rate; this pulsatile pressure inhibits sympathetic 
discharge by initiating volleys of baroceptor impulses which travel 
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along the nucleus of the solitary tract to the medial, vagal portion of 
the vasomotor center (Abrahams et al., 1964; Dell, 1972; Gero and Gerova, 
1962; Green and Heffron, 1968). 
The bilateral portion of the vasomotor center is tonically active, 
continuously transmitting impulses through adrenergic vasoconstrictor 
nerve fibers to all the peripheral blood vessels excepting the capil-
laries (Delius et al., 1972; Grollman, 1969; Guyton, 1966; Hagbarth and 
Vallbo, 1968). Adrenergic innervation is responsible for vasomotor 
tone, a slight, constant constriction of the peripheral blood vessels 
(Bolme et al., 1967a; Cobbold et al., 1963; Hadjiminas and Oberg, 1968). 
Tonus of the larger arterial blood vessels of the body is also partly 
accounted for by basal adrenal medullary secretion of norepinephrine 
(Guyton, 1966; Zweifach, 1968). In contrast, cholinergic vasodilatory 
fibers are not influenced by the baroreflex (Uvnas, 1960..§!_). There is no 
intrinsic tonicity, therefore, to their innervation of blood vessels. 
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The influence of the vasomotor control center upon basal vascular 
tone is predominant in the arterial vessels of skeletal muscle (Barcroft, 
1968). These vessels receive more vasomotor stimulation and are more 
involved in the baroreflex arc than are either the veins (Folkow,1962.Q_; 
Hadjiminas and Oberg, 1968), the renal and skin circulation, or the 
vascular bed of the intestine (Hadjiminas and Oberg, 1968; Lofving, 
1961..§!_; Lofving, 1961.Q_). These regional discrepancies may result from 
selective negative feedback; that is, elevation in the controlled vari-
able (central blood pressure) stimulates baroceptor reflex inhibition of 
only certain peripheral vasoconstrictor fibers (Lofving, 1961..§!_; Lofving, 
1961.Q_). Because the blood vessels in skeletal muscle constitute approxi-
mately half of the entire circulatory system (Guyton, 1966), it is not 
surprising that the reactivity of these vessels is considered an impor-
tant regulatory element in circulatory homeostasis (Heymans and Neil, 
1958; Peterson, 1963; Scher and Young, 1963). 
Control of Peripheral Resistance 
Peripheral resistance in general, and the pressor response in 
particular, are indirectly mediated by vasomotor fibers from the motor 
and premotor cortex, the orbital area of the forebrain, the rostral 
cingulate gyrus, the postero-lateral hypothalamus, and the anterior 
temporal lobe, all of which stimulate the vasomotor center (Guyton, 
1966; Lofving, 1961..§!.)· The principal site of peripheral resistance in 
all body tissue is the arteriole (Cobbold et al., 1963; Freis, 1960; 
Rodda and Denny-Brow, 1966) and it is the only segment of the circula-
tion that is innervated by both constrictor and dilatory vaomotor fibers 
(Bolme et al., 1967~). 
Characteristics of Smooth Muscle Cell Response 
The smooth muscle cell in the arterial microcirculation is consi-
dered at once a receptor and an effector unit (Golenhofen, 1968; Penaz, 
Burianek, and Semrad, 1968), As a receptor cell, the smooth muscle cell 
responds to vasomotor activation (Barcroft, 1968; Golenhofen, 1968); as 
a stretch receptor (Penaz et al., 1968), it also responds to the two 
autonomous, local influences of perfusion pressure and the metabolic 
processes of blood-tissue exchange (Raddy et al., 1968; Penaz et al., 
1968; Thron, 1968; Zweifach, 1968). The attendant effector response 
within the cell is presumed to be a mechanical reflex of negative feed-
back which controls the diameter of the blood vessel (Delius et al., 
1972; Penaz et al., 1968). The delay, or phase lag, between the cellu-
lar receptor and effector responses produces oscillation, or resonance, 
in the internal muscle layer of the arteriole (Folkow, 1964~; Flokow, 
1964.£; Johnson, 1964; Penaz et al., 1968; Thron, 1968). It is believed 
that efferent impulses from the smooth muscle cells in the arterioles 
contribute their part to the reflex arc governing systemic blood pres-
sure (Rosenbaum and Race, 1968). 
Noradrenergic Innervation of the Carotid 
Arterial Structures 
An abundance of cervical sympathetic fibers innervate the branching 
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of the carotid sinus and the internal carotid artery (Reis and Fuxe, 
1968). Synapses exist between the carotid sinus nerve endings (vagal 
and glossopharyngeal) and sympathetic fibers (Koizumi and Sato, 1969), 
and norepinephrine stores appear to be released within the walls of the 
carotid sinus and the carotid artery by electrical stimulation of the 
cervical sympathetic nerve (Reis and Fuxe, 1968). Nonetheless, nore-
pinephrine apparently neither influences the distensibility of the 
internal carotid artery in man (Abraham, 1969 :; Arndt, Klauske, and 
Mersch, 1968), nor in the favored experimental model of essential hyper-
tension in man, the spontaneously hypertensive rat (SHR). Intravenous 
and intracarotid administration of norepinephrine does not reduce 
internal carotid arterial blood flow in humans (Greenfield and Tindall, 
1968), and although carotid occlusion in the dog and simulated hemorhage 
in man (induced by lower body suction) each activate the reflex in 
response to fall in arterial pressure, neither maneuver produces signi-
ficant increase in catecholamine secretion (Hodge, Lowe, and Vane, 
1969). 
Carotid Sinus/Aortic Arch Inhibitory 
Reflex Function in Hypertension 
In essential hypertension, it has been thought that the baroceptors 
cease to function after becoming sensitized and finally exhausted by 
persistent high blood pressure (Abraham, 1969) . This circumstance has 
been understood to produce a "resetting" of the protective reflex of 
negative feedback at higher levels of systolic pressure (Freis, 1960; 
Peterson, 1961) . 
If local adrenergic influence upon the carotid sinus stretch reflex 
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must be discounted as a direct contributing factor to the resetting of 
threshold, reduction in arterial compliance from medial hypertrophy is 
indeed believed to influence threshold (Bristow et al., 1969). There is 
now sufficient evidence from the study of hypertensive animal and human 
subjects to suggest that resetting of baroceptor threshold is a function 
of hypertrophically induced incompliance at the site of the receptors. 
In other words, it is the arterial walls, rather than the receptors, 
that may have become reset (Folkow et al., 1972). For example, studies 
of renal hypertensive rabbits (Aars, 1969~; Aars, 19691) have shown that 
resetting of the reflex occurred after thickening of aortic tissue had 
taken place in the area of the baroceptors. Modification of the vessel 
wall mass took place within a week in some animals. 
Hypertrophy has been described as a rebuilding, rather than a 
sclerotic narrowing, of the vessel wall (Folkow et al., 1970~; Folkow 
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et al., 19701), It is viewed as a form of vascular adaptation whereby 
resistance to blood flow rises throughout the arterial system in propor-
tion to intermittent or prolonged elevation of blood pressure (Pickering, 
1968; Sivertsson, 1970). Hypertrophy of the vessel media inside the 
smooth muscle sheath increases the wall/lumen ratio which then encroaches 
upon the lumen (the vessel bore) in proportion to average pressure load 
(Folkow et al., 1972; Sivertsson, 1970; Suwa and Takahashi, 1971). 
Furthermore, venous occlusion plethysmography on human subjects with 
essential hypertension has shown that resistance in the hand and forearm 
persists and may increase at maximal vasodilatation (Conway, 1963; 
Folkow, 1956; Folkow, Grimby, and Thulesius, 1958; Sivertsson, 1970; 
Sivertsson and Olander, 1968). These experiments have utilized high, 
indirect plethysmograph temperature (33°-43°C) in order to minimize 
sympathetic vasoconstrictor fiber discharge in the limb under study. 
Similar results have been obtained in SHR in studies of flow resist-
ance in both the isolated limb and in the entire systemic circulation 
(Folkow et al., 1970_£). Resistance to blood flow following maximal 
vasodilatation was found following Nembutal anesthesia (3 mg./100 g. 
body weight), arterial perfusion of the isolated hindquarter (constant 
flow with oxygenated plasma substitute), and injections of the vasodi-
lator, papaverine (a benzylisoquinoline alkaloid of opium). Blood flow 
resistance in SHR was found to increase in approximate proportion to 
blood pressure level under resting conditions when the sympathetic 
nervous system was blocked by guanathidine (0.51 mg./100 g. body weight), 
the root of the aorta perfused with an oxygenated plasma substitute, 
and the systemic circulation (excepting the coronary arteries) maximally 
dilated by intravenous injection of isopropylnoradrenaline and acetyl-
choline (Folkow et al., 1970~). 
Hypertrophy of the arterial vessels apparently coexists with normal 
basal tone; that is, with normal smooth muscle activity (Conway, 1963; 
Pickering, 1936; Prinzmetal and Wilson, 1936; Sivertsson, 1970). Al-
though associated with a normal range of resistance adjustments (vaso-
dilatation and vasoconstriction) (Sivertsson, 1970), hypertrophic alter-
ation of the arterial walls has the overall effect of raising the 
baseline for these adjustments (Folkow et al., 1970~; Sivertsson, 1970). 
Flow resistance in the blood vessel is profoundly affected by 
hypertrophy since resistance has been described as being inversely pro-
portional to the fourth power of the vessel radius (Sivertsson, 1970). 
Finally, hypertrophy is associated with in~reased reactivity to nor-
epinephrine. Graded norepinephrine infusion to the hand in the hyper-
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tensive subject administered through the ipsilateral brachial artery at 
dosages above threshold has produced markedly greater increase in flow 
resistance than that observed in the control subject (Sivertsson and 
Olander, 1968). The response indicates a more extreme attrition of the 
lumina for a given degree of smooth muscle contraction, and therefore 
represents a kind of enhanced vascular reactivity (Sivertsson and 
Olander, 1968). 
Influence of the Central Nervous System 
upon Baroceptor Function 
Aside from morphological change at the site of the baroceptors, 
servo-control of blood pressure in the reflex arc may be "over-ridden" 
in hypertension by higher centers of the brain (Folkow, 1962~; Manning, 
1965). Anatomical and functional links between hypothalamic nuclei and 
the carotid sinus baroceptors have been demonstrated. Applying static 
pressure pulses to these receptors, Hilton and Spyer (1969) recorded 
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both activation and inhibition of neurons within the anterior hypothalamic 
depressor area. Vagal activity, which normally lowers blood pressure, 
can be inhibited by hypothalamic stimulation: electrical stimulation of 
the lateral and posterior hypothalamus in both anesthetized and artifi-
cially respired unanesthetized cats can induce hypertension, excitation 
of the bilateral portion of the vasomotor center, and inhibition of the 
efferent cardiac vagal impulses which form part of the baroceptor 
response (Gebber and Snyder, 1970; Hilton, 1965). 
Summary and Conclusions 
The baroceptors are the primary sensors of a fairly complicated 
33 
system for blood pressure control. They are monitors of heart rate and 
of intrasinusal and aortic pressure, and ensure proper blood supply to 
the brain. In addition, the direct nervous connection of the baroceptors 
to the vasomotor center involves them in the maintenance of vasomotor 
tone in all segments of the peripheral circulation with the exception of 
the capillaries. 
If a disturbance in the carotid sinus/aortic arch reflex exists in 
essential hypertension, it probably resides in these receptors and in 
the arterial media that surrounds them. For it is thought that the pro-
tective function of the baroceptors can be overwhelmed by neural bom-
bardment of the bilateral vasomotor center from the hypothalamus during 
emotional arousal, and that their threshold of response can either 
become elevated or their sensitivity destroyed by sinusal and aortic 
hypertrophy. 
CHAPTER IV 
CIRCULATION IN SKELETAL MUSCLE 
The Relationship Between Musculoskeletal Behavior 
and Circulation in Muscle 
Hemodynamics and Metabolism in Normally 
Functioning Muscle 
Skeletal muscle blood vessels are known to react as sensitively to 
central and sympathetic stimulation as does the visceral circulation. 
Circulation in skeletal muscle is controlled by the same cortical and 
diencephalic centers that alter blood flow to the internal organs, and 
by those same receptor-effector areas of the pons and medulla oblongata 
that reflexively adjust blood flow to both the viscera and the brain 
(Hilton, 1968; Hudlicka, 1968). Skeletal muscle blood flow is controlled 
predominantly by sympathetic cholinergic vasodilatory fibers that ori-
ginate from the upper and midbrain (Eliasson et al., 1951; Golenhofen, 
1968; Uvnas, 19602_; Uvnas, 1960£_). It will be recalled that vascular 
tone in skeletal muscle is adrenerglcally mediated and is under the 
direct control of the vasomotor center of the brainstem (Barcroft, 
1968). Blood supply to muscle is therefore continuously influenced by 
two neurologic systems. It has also been noted that the bilateral, 
excitatory portion of the vasomotor center can be stimulated by vaso-
motor fibers originating in the motor brain and hypothalamus, and that 
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this stimulation can override the vagal, inhibitory influence of the 
medial vasomotor center (Delius et al., 1972; Gebber and Snyder, 1970; 
Hagbarth and Vallbo, 1968; Hilton, 1965; Lofving, 196la). 
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Full contraction and relaxation of muscle in exercise permits the 
uptake of oxygen and glucose, the acceleration of muscle metabolic rate, 
and the clearance of sodium and iodine from muscle tissue (Brod, 1962; 
Hyman et al., 1959; Renkin, 1968; Rosell and Uvnas, 1962). These pro-
cesses together bring about what is known as the "breakthrough" of 
metabolites (Folkow, 1964~). It is the flow of blood and blood-borne 
constituents between the distal end of the arterial tree (the arterioles, 
the metarterioles, the precapillary sphincters, and the capillaries) and 
the tissue cell (Freis, 1960; Freis, 1969; Imbriglia, 1959; Sommers, 
1959). The breakthrough counteracts and finally negates the initial 
adrenergic effect of vasoconstrictor fibers upon muscle vessels (Folkow, 
1964~; Kjellmer, 1965). Metabolites are, in fact, powerful dilator 
substances that can quickly reinstate optimal diffusion capacity in the 
microcirculation during lumbar sympathetic (adrenergic) chain stimulation 
even as the larger, more distal vessels remain constricted (Folkow, 
Sonnenschein, and Wright, 1968). 
Sympathetic cholinergic vasodilator fibers also dilate the blood 
vessels of skeletal muscle in exercise (Roddie, 1966; Uvnas, 1960~). 
Muscular contraction itself, however, and the motor innervation origi-
nating in the motor and premotor cortices of the precentral gyrus, are 
the most important mediators of peripheral vasodilation (Barcroft, 1968; 
Hilton, 1968; Hudlicka, 1968; Zanchetti, 1970). In response to stren-
uous exercise, blood flow in skeletal muscle in normal humans can 
increase from 1 to approximately 20 liters per minute (Barcroft, 1968), 
reflecting the shift of blood from the skin, the kidneys, and the 
splanchnic area to skeletal muscle (Brod, 1962). Under these condi-
tions, cardiac output increases from 5 to approximately 25 liters per 
minute and blood pressure remains essentially the same (Barcroft, 1968). 
Adams et al. (1969) measured circulatory response in the aorta, the 
mesenteric artery, and the external iliac artery in the cat during 
fighting behavior. After an initial moderate rise, blood pressure 
returned to normal resting level and remained at that level throughout 
the fighting episode. In a complementary study, Baccelli et al. (1968) 
found that when the hindlimbs supported the cat in combat, vasodilata-
tion occurred in the iliac bed after an initial vasoconstriction, indi-
cating that vasodilatation fulfills a metabolic function under local 
regulation. However, when the animal fought while lying on its side, 
iliac vasoconstriction took place, accompanied by a moderate but sus-
tained rise in blood pressure. 
Gross Skeletal Muscle Behavior in the 
Hypertensive Organism 
Even though response in muscle circulation to restraint or immobil-
ization has been largely the subject of animal, rather than human, 
research and although there is no disease in any experimental animal 
that is exactly comparable to essential hypertension in man (Gitlow et 
al., 1969), extrapolations can be made from animal research to the 
possible role of muscular rigidity in the pathology of essential hyper-
tension since this rigidity may be a distinguishing somatic trait in t he 
disease. 
In essential hypertension, an asynchrony may exist between the 
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muscular and circulatory adjustments which ready an individual for an 
aggressive act and the motor inhibition of that act, an inhibition that 
cannot prevent the continued mobilization and tensing of muscle (Diamond, 
Balvin, and Diamond, 1963; Shmavonian et al., 1968). In keeping with 
this hypothesis, the observation has been made that the hypertensive 
person displays a state of muscular preparedness (Brod, 1962) as if 
"mobilized for combat" (Wolf et al., 1955). He may thus be demonstrat-
ing what Graham (1972) has called "the correlation of non-language 
behavior with disease." 
Studies of hypertensive animals also report idiosyncrasies in gross 
muscular behavior. Griew (1966) noted less spontaneous activity in 
young SHR than in control rats in swimming behavior and in the Open 
Field situation. Welner et al. (1968) reported constrained behavior in 
young, pre-hypertensive "sensitive" rats in a cage setting designed for 
exploration. Cornary arteriosclerosis has been found in swine isolated 
from the age of 6 to 15 months (Ratcliffe et al., 1969), and the separ-
ated animals also displayed withdrawal behavior by their unwillingness 
to move about their cages and by their refusal to eat. Other swine, 
subjected to crowding over the same period of time, did not develop 
sclerotic lesions. It was therefore concluded that a disturbance in 
behavior pattern may have been a cause of disease. 
Metabolic Disturbances in Muscle 
Anoxia in Body Tissue 
Hypertension in humans, like "muscle degeneration disease" in swine 
(Briskey, 1964), has been classified as one of the anoxic diseases 
(Hicks and Warren, 1950). The two areas of the human body to which this 
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generalization applies most appropriately are the kidneys and the skele-
tal muscles. Noradrenergic sympathetic influence upon either the renal 
artery or the afferent renal glomerular arterioles can cause partial 
anoxia as well as ischemia in the kidney (Lubash, 1968; Pfeiffer and 
Wolff, 1950; Pitts, 1968; Sommers, 1959). High sustained peripheral 
resistance can produce anoxia in skeletal muscle by bringing about 
degenerative changes in the elastic fibers of the arterioles that will 
interfere with efficient capillary blood-tissue interchange (Freis, 
1960; Freis, 1969; Imbriglia, 1959). Degrees of anoxia can also be 
present in skeletal tissue in those states of emotional arousal in which 
anticipatory cardiovascular response and muscular immobility concur; 
therefore, it is believed that bodily restraint, whether imposed upon an 
organism, or deliberately self-imposed, can influence muscle metabolism 
in a significantly different way than does exercise (Brod, 1962; Charvat 
et al., 1964). 
Muscle Pathology in Swine 
Of all animal species, it is the pig that is regarded as the more 
appropriate subject for the investigation of homeostatic reflex mecha-
nisms and cardiovascular function as these processes occur in man (Pekas 
and Bustad, 1965; Rowsell, 1968; Schmitt, 1968). Muscle degeneration 
disease in swine also seems to offer an adequate illustration of how 
strongly circulation in striated muscle may affect these processes in 
hypertensive man. 
The disease is a pathological reaction in skeletal muscle to such 
stressors as fatigue, emotional excitement , noise, anoxia , high tempera-
tures, and bodily restraint (Briskey, 1964; Briskey, 1969; Forrest 
et al., 1968; Judge, Briskey, and Meyer, 1966). Degenerative lesions 
have been a consistent finding in post-mortem analysis of samples of 
longissimus dorsi muscle in stress-susceptible swine (Poland China, 
heat-stressor-susceptible) following immobilization stress (Judge, 
Cassens, and Briskey, 1967; Judge et al., 1967). The muscle tissue has 
been found to be in a condition of myomalacia, being typically soft, 
pale, and exudative in contrast to the firm, well-pigmented muscle 
tissue of normal swine at time of exsanguination (Briskey, 1964; Forrest 
et al., 1968). Judging from the relatively rapid rate of rigor mortis, 
the breakdown of carbohydrates had probably proceeded under relatively 
anaerobic conditions in the living animal (Henrickson, personal com-
munication; Judge, Cassens, and Briskey, 1967). 
Vascular Pathology in Skeletal Muscle and 
Viscera in the Human 
In essential hypertension, degeneration of the arteriolar network 
in skeletal muscle and in the body organs are evidently identical. The 
salient feature of this degeneration in all body tissue has been de-
scribed as "a diffuse lesion of the arteriolar bed" (I mbriglia, 19 59). 
It is the result of a pathologic progression of hypertrophy, fibrosis, 
and necrosis (Freis, 1960; Freis, 1969; Imbriglia, 1959; Sommers, 1959). 
These structural changes reflect a depression in the metabolism of the 
smooth muscle cell brought about by anoxia (Robinson, 1960; Tabian, 
1960). The level of the nucleotide, adenosine triphosphate (ATP), in 
the nucleoplasm and cytoplasm of the cell is lowered because the l evel 
of ingredients necessary to its reconstitution in the mitochondria, s uch 
as adenosine di~hosphate (ADP) and oxidized cellular nutrients (fats, 
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proteins, and carbohydrates), is itself lowered (Guyton, 1966; Robinson, 
1960; Tobian, 1960). Loss of ATP has serious consequences. The processes 
of oxidative phosphorylation and of active transport across the cell 
membrane are impeded, and relaxation of muscle fiber in the blood vessel 
wall is inhibited (Guyton, 1966; Robinson, 1960; Tobian, 1960). The 
loss also disturbs intracellular-extracellular ionic balance (Na/K 
ratio) by tending to reverse the normal concentration gradient of these 
ions (Guyton, 1966). Deprived of the energy of ATP, the sodium pump 
cannot prevent swelling of the smooth muscle cell brought about by the 
entry of sodium into the cell and the diffusion of potassium into the 
extracellular fluid (Guyton, 1966; Robinson, 1960; Tobian, 1960; 
Solomon, 1962). 
Summary and Conclusions 
Musculoskeletal behavior in both man and animal can evidently have 
significant effects upon cardiovascular homeostasis and upon the condi-
tion of skeletal muscle tissue itself. Full discharge of muscular 
tension following mobilization of whole body musculature allows blood 
pressure to return to normal levels after the initial elevation that 
normally accompanies sympathetic arousal. By initiating dilatation of 
muscle blood vessels, full discharge also permits optimum passage of 
nutriments and wastes to and from muscle tissue. 
There seems sufficient evidence from observations of hypertensive 
man, of the spontaneously hypertensive rat, and of swine afflicted with 
coronary heart disease, to presume that some relationship must exist 
between constrained motor behavior and the autonomic, visceral component 
in cardiovascular disease. The relationship is perhaps best illustrated 
at the site of the arteriole in both muscle and viscus. Here it has 
been seen that sympathetic activation and muscular constraint, or 
immobilization, may be sufficiently antithetic in their circulatory 
effects to produce anoxia and an anaerobic metabolic chain reaction that 
can be undermining to the entire microcirculation of the body. 
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CHAPTER V 
THE PSYCHOPHYSIOLOGY OF ESSENTIAL 
HYPERTENSION 
The Relationship between Physiological Response 
Patterns and Personality in Essential 
Hypertension 
It may be true, as Pribram (1967) has stated, that sensory, hormonal, 
and neurosecretory receptor-effector processes in the central nervous 
system and between the central nervous system and the target organs of 
the body form the physiological substrate of mood. Mood is probably as 
Nauta (1963) has described it, "the attitude of the organism toward its 
outer and inner environments". In the context of opinions such as 
these, it seems reasonable to consider three questions. (1) Can the 
psychological correlates of noradrenergic activation and the hyperten-
sive pressor response be translated into long-term psychological state-
ments (Graham, 1972) to describe personality in essential hypertension 
in terms of specificity-of-attitude? (2) Are these psychological state-
ments sufficiently specific to hypertension that they do not risk being 
applicable to other functional disorders as well? And (3) can specifi-
city-of-attitude be correlated with certain kinds of individual autonomic 
response specificity in essential hypertension such as pressor hyper-
reactivity, and the "anger-out", norepinephrine-epinephrine response? 
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Specificity-of-Attitude in Essential 
Hypertension 
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After many years of research by many different investigators, des-
criptions of the hypertensive personality have evolved a common core. 
Competitiveness and compulsive drive apparently coexist with feelings of 
inadequacy that are sufficient to inhibit self assertion. These incom-
patible needs produce frustration and conflict that are both internally 
and externally directed, as first one, and then the other, of the indi-
vidual's major drives gains ascendency (Ackerman, 1950; Alexander, 1948; 
Alexander, 1950; Binger, 1951; Dunbar, 1947; Ferris et al., 1948; Rambling, 
1959; Hamilton, 1955; Harris and Forsyth, 1973; Harris et al., 1953; 
Hinkle and Wolff, 1962; Jenkins, Rosenman, and Friedman, 1968; Kemple, 
1945; Matarazzo, 1954; Mills, 1959; Mordkoff and Parsons, 1968; Reiser, 
Ferris, and Levine, 1937; Rennie, 1939; Rosenman et al., 1968; Saslow 
et al., 1950; Saul, 1939; Shapiro, 1960; Sokolow et al., 1962; Syme, 
1968; Wolf and Wolff, 1946; Wolf et al., 1955; Wolff, 1953). It is this 
ambivalence in hypertension that forms the nexus of psycho-diagnostic 
study of the disease: the hostility that is neither expressed nor 
repressed, and the anxiety that as product of the conflict, becomes a 
secondary, generalized response (Binger, 1951; Graham, 1972; Rambling, 
1959; Saul, 1939; White, 1964). 
Descri ptions of the hypertensive personality f it fairly well i nto 
the specificity-of-attitude formulation (Grace and Graham, 1952); namely, 
that the individual feels threatened by personal interaction and must be 
ever watchful and defensive (Graham et al., 1962). It should be poin t ed 
out, however, that gastrointestinal ulcers, rheumatoid arthritis, ulcer-
ative colitis, Raynaud's disease, migraine, and vasovagal fainting are 
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all presumed psychosomatic disorders in which these same personality 
variables of inhibited hostility and anxiety figure prominently (Alexander, 
1950; Graham, 1972). This being so, there does not appear to be a 
clear-cut specificity-of-attitude that can be correlated with any one 
particular organic dysfunction. 
The apparent trait constellation in hypertension might nevertheless 
be considered a constellation of chronic emotions (Graham, 1972). This 
constellation of chronic emotions not only exists in conjuction with 
hormonal and neurophysiological states that may be pathologically 
altered, it may also be both stimulus and response to those somatic 
states (Ausubel, 1966; Tepperman, 1968). In this sense, it is possible 
that both the behaviors and the physical symptoms found in hypertension 
are forms of maladaptive compensation (Ausubel, 1966). 
Autonomic Response Specificity in Essential 
Hypertension 
Experiments directed to the question of autonomic response specifi-
city (Lacey and Lacey, 1958; Lacey, Bateman, and VanLehn, 1953) have 
demonstrated that presser hyperreactivity is a characteristically domi-
nant response in essential hypertension (Engel and Bickford, 1961; Moos 
and Engel, 1962). This evidence and observations of skeletal muscle 
behavior in hypertensive humans suggest that it may be the patterning of 
autonomic and motor responses that differentiates essential hypertension 
from other psychosomatic disorders (Buss, 1966; Brod, 1962; Wolf et al., 
1955). The concept of patterning has been strongly supported by the 
comparative study of essential hypertension and rheumatoid arthritis 
(Moos and Engel, 1962), for even though relaxation procedures have shown 
that tautness of the skeletal musculature contributes to chronically 
elevated blood pressure (Datey et al., 1969; .Jacobson, 1939; Jacobson, 
1940; Wallace, 1970), muscle behavior is clearly not the principal 
determinant of autonomic response specificity in essential hypertension. 
Muscle action potential (MAP) recordings of the electromyogram (EMG) and 
blood pressure readings were taken of individ·uals with rheumatoid arth-
ritis and of another group of individuals with hypertension during 
conditioning to meaningful verbal stimuli and during semantic generali-
zation (Moos and Engel, 1962). In the arthritic group, higher EMG 
activity in symptomatic muscles and less adaptation in these muscles 
were matched in the hypertensive group by higher and more sustained 
systolic and diastolic blood pressure, and relative lack of adaptation 
in blood pressure. 
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This kind of between-subject variance has also been observed in 
healthy, adult human subjects monitored for multiple peripheral responses 
while responding to the same stressful environmental stimuli (Ax, 1953). 
It has also been observed that normal conscious cats show individual 
differences in predominance of a particular physiological variable 
within the context of generalized sympathetic arousal during stimulation 
by chronically implanted electrodes in the hypothalamic area for the 
defense reaction (Hilton, 1965). 
It is probable that idiosyncratic psychophysiological response pat-
terns in all organisms are innately elicited by emotionally provocative 
stimuli, and are either altered or maintained over time by varieties of 
reinforcement according to the principles of instrumental learning 
(Benson et al., 1969; Benson et al., 1971; Blanchard and Young, 1973; 
Brener and Kleinman, 1970; DiCara and Miller, 1968~; DiCara and Miller, 
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1968E_; Dicara and Weiss, 1969; Herd et al., 1969; Katcher et al., 1969; 
Miller and Banuazzi, 1968). It must be said, however, that although 
organisms evidently have an inherent capacity to be continuously modified 
and developed in all their life systems by learning (Lang, Rice, and 
Sternbach, 1972), base levels of individual response, in contrast to 
magnitude of change in response, tend to be consistent over time except 
as chronic pathology changes the innate state (Johnson, Hord, and Lubin, 
1963; Oken et al., 1962; Wenger et al., 1960). 
Correlation Between Specificity-of-Attitude and 
Autonomic Response Specificity 
Investigators have sought to establish a link between specificity-
of-attitude and autonomic response specificity in several different 
ways. The steps in this process will be described in what would seem to 
be a logical, if not necessarily chronological, order. 
First, there have been attempts to clearly distinguish between the 
states of anger and depression. Studies of frustration in normal adults 
(Funkenstein, King, and Drolette, 1954) have defined anger as "anger-out", 
meaning inhibited, but nonetheless outward-directed anger, and depression 
as "anger-in", or anger that is both inhibited and directed towards the 
self. 
Secondly, experiments have been designed to differentiate different 
emotions physiologically. Ax (1953) demonstrated that the emotions of 
anger and fear produce different physiological patterns of response in 
normal human subjects exposed to anger-provoking and fear-provoking 
situational stress. In fear, subjects showed greater increments in 
levels of skin conductance, in number of muscle tension peaks (frontalis 
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muscle), and in respiration rate. There were greater increases in heart 
rate and systolic blood pressure in fear than in anger, but these differ-
ences did not reach significance. In anger, in contrast to fear, sub-
jects showed elevated diastolic blood pressure, decreased heart rate, 
increase in muscle potentials, and increase in number of galvanic skin 
responses (GSR). 
J. Schachter (1957) published a study undertaken partly in col-
laboration with Ax (1953), in which he tested the blood pressure response 
in hypertensive, and potentially hypertensive, persons in the experimental 
situation of the Ax study, with the data from the subjects of that study 
serving as the control, and with the added variable of the cold-pressor 
test as a pain stimulus. Blood pressure response in fear, anger, and 
pain proved to be relatively greater in the hypertensive subjects, as 
did the intensity of their emotional reactions, expressed either verbally 
or in motor behavior. 
The hypothesis that elevation in blood pressure and "generalized 
physiological over-response" (Oken et al., 1962) result from inhibited 
anger has been tested. Blood pressure, heart rate, and verbally ex-
pressed or behaviorally displayed anger were recorded in a normotensive, 
mixed group of psychiatric patients during stressful interviews over a 4 
day period. Increase in cardiac output occurred most characteristically, 
but those subjects who tended to inhibit their anger had higher diastolic 
and lower systolic blood pressure than those who gave free expression to 
their emotions (Oken, 1960; Oken et al., 1962). 
Third, research on the catecholamines growing out of investigations 
of autonomic balance (adrenergic/cholinergic) (Eppinger and Hess, 1910; 
Wenger, 1941) uncovered individual differences in internal secretion of 
norepinephrine and epinephrine within mixed psychiatric patient groups 
(Funkenstein, Greenblatt, and Solomon, 1952). These differences were 
detected by the use of intramuscular injection of the parasympathetic 
stimulant, mecholyl (acetyl betamethyl choline), and intravenous injec-
tion of epinephrine, alone and in combination with mecholyl. This 
technique, developed by Wenger (1941), proved useful in determining 
favorable prognosis for electroconvulsive shock therapy (Funkenstein, 
Greenblatt, and Solomon, 1948; Funkenstein, Greenblatt, and Solomon, 
1950; Funkenstein, Greenblatt, and Solomon, 1951). 
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Continued, psychologically oriented research on the catecholamines 
established that high urinary excretion levels of norepinephrine and its 
metabolites generally correlated well with either active, aggressive, or 
agonistic behavior, and that epinephrine and its metabolite, metan-
ephrine, seemed most typically to be excreted in states of fear, depres-
sion, and anxiety (Elmadjian, Hope, and Lamson, 1958; von Euler and 
Lundberg, 1954; Hoagland, 1961). Silverman and Cohen (1960) found 
positive correlation between emotional state, blood pressure response, 
g-tolerance and urinary excretion levels of catecholamines in human 
subjects undergoing projective testing [focused thematic test (FTT)] and 
centrifuge stress. Significant correlations were found between anxiety, 
systolic hypotension, low g-tolerance, and high excretion levels of 
epinephrine on the one hand, and impulsiveness, aggressiveness, rela-
tively high systolic blood pressure, high g-tolerance, and high excre-
tion levels of norepinephrine on the other. 
Injection and infusion studies of the catecholamines in human sub-
jects have provided further evidence of the autonomic stereotype of 
epinephrine and norepinephrine, the general patterns of emotional and 
physiological response remaining true. Ax (1960) essentially replicated 
the physiological response patterns of fear and anger (Ax, 1953) with 
injections of norepinephrine bitartrate and epinephrine in 5 of the sub-
jects of the original study. There were anomalies in the results (e.g. 
a sharp rise in diastolic blood pressure following injection of epin-
ephrine) that were considered to be reactions to the injection procedure 
itself. 
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The cardiovascular effects of norepinephrine and epinephrine infusion 
were observed in patients with essential hypertension and in a normo-
tensive group (Goldenberg et al., 1948), showing that hypertensive 
persons were more responsive to norepinephrine. In normal subjects, Ax 
et al. (1969) found that cardiac output showed greater increase in 
response to epinephrine infusion and greater decrease in response to 
norepinephrine, and that greater skin vasoconstriction (inferred from 
finger pulse pressure) resulted from norepinephrine infusion. The 
findings on cardiac output and skin blood flow in this study generally 
substantiated the results of a report on autonomic response patterns in 
response to epinephrine and norepinephrine infusion in normal persons by 
Wenger et al. (1960). 
The Significance of Genetics to 
Behavioral Specificity 
Investigation of pepsinogen secretion (Mirsky, 1958) and of pupil-
lary and vascular dilatation (Richmond and Lustman, 1955) in human 
neonates has given experimental support to the belief that patterns of 
autonomic response may be inherited (Buss, 1966; Hines and Brown, 1933; 
Sivertsson, 1970). The belief has been further substantiated by the 
discovery of high heritability of hypertension in humans (h2=o. 76 for 
systolic pressure) in monozygotic twin studies (Hines, Mcilhaney, and 
Gage, 1957; Simon et al., 1968; Vander Molen et al., 1970). The very 
fact that strains of rats, such as SHR, have been selectively bred to 
become hypertensive also supports the premise of a strong hereditary 
component to the disease (Knudsen et al., 1973). It will be remembered 
that hypertension is believed to be polygenetically determined in both 
man and SHR (Ch.II, p.21). 
At present, speculation on the etiology of essential hypertension 
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is centered on the "trigger mechanism" that leads to its expression. It 
is conceivable that a genetically determined predisposition to hypertro-
phy in smooth muscle exists in certain individuals and that this predis-
position is the primary cause rather than the consequence of high blood 
pressure (Folkow et al., 19702_; Folkow et al., 197Q_!?_; Sivertsson, 1970). 
It is likewise conceivable that the inherited trigger mechanism might be 
an exaggerated pattern of centrally regulated sympathetic discharge 
that, in the course of time, raises and maintains the pressure load at 
the medullary regulatory centers and throughout the entire cardiovascular 
system (Buss, 1966; Hines and Brown, 1933; Folkow and Neil, 1971; 
Sivertsson, 1970). It has been seen (Ch.II, p.20) that this pattern of 
central nervous activity is mediated by high concentrations and activity 
levels of norepinephrine, and that it produces aggressive, hostile 
behavior in SHR. Extrapolation of these data to human emotional behavior 
does not seem invalid since hypertension in this animal is deemed such 
an excellent analogue of human hypertensive disease. 
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Summary and Conclusions 
The personality variables in essential hypertension, although not 
unique to the disease, do seem to be associated with an autonomic response 
specificity in which the blood pressure response is predominant and a 
chronic norepinephrine-like state of arousal exists. There are perhaps 
chronic attitudes in hypertension as well. Although external circumstance 
must surely have some part in their formation, there are indications 
from animal studies that inheritance may play a part in an excitability 
of temperament that is corticohypothalamic in origin. There is also an 
hypothesis from observations of both animal and man that increased peri-
pheral resistance may be brought about by an inherited tendency to smooth 
muscle hypertrophy. 
Essentially, then, the hypertensive state describes a closed system 
that is vulnerable to the dangers of positive feedback. As part of this 
system, the attitudes and/or emotional behaviors of the hypertensive 
organism can be thought of as both genesis and product of a complicated 
pathology. 
CHAPTER VI 
THE SUMMARY AND CONCLUSIONS 
This paper has been a review of some of the published literature 
on essential hypertension. It has dwelt with what have seemed to be six 
of the more distinguishing features of the illness. In the process of 
defining these features, there has been an attempt to show that a psycho-
somatic disorder can be examined to advantage as an interrelationship 
between systems. It has in fact become apparent that there is inter-
dependence and some evidence of synergism between the psychological and 
physiological systems that have been chosen for discussion. Sympathetic 
(noradrenergic) and renal-adrenocortical function, the baroceptor reflex, 
smooth muscle activity in all body tissue, skeletal muscle behavior, and 
prevailing psychological states all seem, in essential hypertension, to 
reveal degrees of either heightened reactivity, or of pathologic modifi-
cation of tissue and tissue processes that have developed from over-
reactivity. 
It is presumed that these interrelationships of mind and body interact 
with the more global influences of genetic predisposition and total life 
experience. These are influences that incorporate such variables as 
specific organic susceptibility, perception of self, and the complexities 
of motivation. It has been suggested, for example, that smooth muscle 
and centers of the brain that regulate emotionally motivated behavior 
may both manifest the demonstrable heritability of hypertension. Given 
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the genetic factor, essential hypertension may be a form of adaptation 
by the whole person to many different sources of internal and environ-
mental stimulation. The disease may be even more aptly described as a 
form of maladaptation, for it seems characterized by attitudinal and 
physiological overcompensation. It will be necessary to define, ever 
more precisely, how central and peripheral systems interact, and to 
identify the interplay of genetics and environment in mechanisms that 
are psychologic, neurologic, metabolic, and hormonal. 
Some of the symptoms of essential hypertension are probably the 
products of conditioning. This way of evaluating certain elements of 
the disorder not only extends our understanding of them, but also sug-
gests directions for therapy. Techniques continue to be developed 
whereby both emotional and visceral behaviors may be modified. These 
therapies hold promise for the individual suffering from perhaps the 
most bewildering of maladies, one in which the afflicted finds himself 
both agent and victim of his own pathology. 
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